Skip to main content
Top
Published in: Gastric Cancer 1/2024

02-11-2023 | Gastric Cancer | Original Article

Ethnic-specific associations between body mass index and gastric cancer: a Mendelian randomization study in European and Korean populations

Authors: Sangjun Lee, Sue K. Park

Published in: Gastric Cancer | Issue 1/2024

Login to get access

Abstract

Background

Given the uncertainties surrounding the associations in previous epidemiological studies, we conducted linear and nonlinear Mendelian randomization (MR) studies to evaluate whether body mass index (BMI) associated with gastric cancer (GC) risk in European and Korean.

Methods

Genome-wide association study-summary statistics were used from the Pan-UK Biobank, the Genetic Investigation of Anthropometric Traits consortium, the K-CHIP consortium, and BioBank Japan. BMI-associated single nucleotide polymorphisms (SNPs) were used as instrumental variables (IVs) in MR to identify the association between BMI and GC. Both linear and nonlinear MR analyses were performed. Sensitivity analyses were also conducted for individuals below or above a BMI of 24 kg/m2.

Results

The study used 22 and 55 SNPs as IVs for BMI in European and Korean populations, respectively. Genetically predicted BMI was positively associated with GC risk in the European population (Odds ratio per 1 kg/m2 increase; 95% CI = 1.17; 1.01–1.36 using simple median method), but no significant association was observed in the Korean population. However, the nonlinear MR identified a U-shaped association between BMI and GC in the Korean population, with both low and high BMIs associated with increased GC risk. A BMI of 24 kg/m2 presented the lowest risk. Sensitivity analyses did not yield any genome-wide significant SNPs.

Conclusion

While MR analysis suggests a linear association between BMI and GC in those of European ancestry, nonlinear MR hints at a U-shaped association in Koreans. This suggests the association between BMI and GC risk may vary according to ethnic ancestry.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. 2018;68:394–424.PubMed Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. 2018;68:394–424.PubMed
2.
go back to reference Colquhoun A, Arnold M, Ferlay J, Goodman K, Forman D, Soerjomataram I. Global patterns of cardia and non-cardia gastric cancer incidence in 2012. Gut. 2015;64:1881–8.PubMedCrossRef Colquhoun A, Arnold M, Ferlay J, Goodman K, Forman D, Soerjomataram I. Global patterns of cardia and non-cardia gastric cancer incidence in 2012. Gut. 2015;64:1881–8.PubMedCrossRef
3.
go back to reference Olefson S, Moss SF. Obesity and related risk factors in gastric cardia adenocarcinoma. Gastric Cancer. 2015;18:23–32.PubMedCrossRef Olefson S, Moss SF. Obesity and related risk factors in gastric cardia adenocarcinoma. Gastric Cancer. 2015;18:23–32.PubMedCrossRef
4.
go back to reference Cancer IAFRO. IARC working group on the evaluation of carcinogenic risks to humans. IARC Monogr Eval Carcinog Risks Hum. 1994;61:45–119. Cancer IAFRO. IARC working group on the evaluation of carcinogenic risks to humans. IARC Monogr Eval Carcinog Risks Hum. 1994;61:45–119.
5.
go back to reference Jang J, Lee S, Ko KP, Abe SK, Rahman MS, Saito E, et al. Association between body mass index and risk of gastric cancer by anatomic and histologic subtypes in over 500,000 east and southeast Asian cohort participants. Cancer Epidemiol Biomarkers Prev. 2022;31:1727–34.PubMedPubMedCentralCrossRef Jang J, Lee S, Ko KP, Abe SK, Rahman MS, Saito E, et al. Association between body mass index and risk of gastric cancer by anatomic and histologic subtypes in over 500,000 east and southeast Asian cohort participants. Cancer Epidemiol Biomarkers Prev. 2022;31:1727–34.PubMedPubMedCentralCrossRef
6.
go back to reference Didelez V, Sheehan N. Mendelian randomization as an instrumental variable approach to causal inference. Stat Methods Med Res. 2007;16:309–30.MathSciNetPubMedCrossRef Didelez V, Sheehan N. Mendelian randomization as an instrumental variable approach to causal inference. Stat Methods Med Res. 2007;16:309–30.MathSciNetPubMedCrossRef
7.
go back to reference Burgess S, Butterworth AS, Thompson JR. Beyond Mendelian randomization: how to interpret evidence of shared genetic predictors. J Clin Epidemiol. 2016;69:208–16.PubMedPubMedCentralCrossRef Burgess S, Butterworth AS, Thompson JR. Beyond Mendelian randomization: how to interpret evidence of shared genetic predictors. J Clin Epidemiol. 2016;69:208–16.PubMedPubMedCentralCrossRef
10.
go back to reference Staley JR, Burgess S. Semiparametric methods for estimation of a nonlinear exposure-outcome relationship using instrumental variables with application to Mendelian randomization. Genet Epidemiol. 2017;41:341–52.PubMedPubMedCentralCrossRef Staley JR, Burgess S. Semiparametric methods for estimation of a nonlinear exposure-outcome relationship using instrumental variables with application to Mendelian randomization. Genet Epidemiol. 2017;41:341–52.PubMedPubMedCentralCrossRef
12.
go back to reference Yengo L, Sidorenko J, Kemper KE, Zheng Z, Wood AR, Weedon MN, et al. Meta-analysis of genome-wide association studies for height and body mass index in ∼700000 individuals of European ancestry. Hum Mol Genet. 2018;27:3641–9.PubMedPubMedCentralCrossRef Yengo L, Sidorenko J, Kemper KE, Zheng Z, Wood AR, Weedon MN, et al. Meta-analysis of genome-wide association studies for height and body mass index in ∼700000 individuals of European ancestry. Hum Mol Genet. 2018;27:3641–9.PubMedPubMedCentralCrossRef
13.
go back to reference Sakaue S, Kanai M, Tanigawa Y, Karjalainen J, Kurki M, Koshiba S, et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nat Genet. 2021;53:1415–24.PubMedCrossRef Sakaue S, Kanai M, Tanigawa Y, Karjalainen J, Kurki M, Koshiba S, et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nat Genet. 2021;53:1415–24.PubMedCrossRef
15.
go back to reference Moon S, Kim YJ, Han S, Hwang MY, Shin DM, Park MY, et al. The Korea biobank array: design and identification of coding variants associated with blood biochemical traits. Sci Rep. 2019;9:1–11.CrossRef Moon S, Kim YJ, Han S, Hwang MY, Shin DM, Park MY, et al. The Korea biobank array: design and identification of coding variants associated with blood biochemical traits. Sci Rep. 2019;9:1–11.CrossRef
16.
go back to reference Delaneau O, Marchini J, Zagury J-F. A linear complexity phasing method for thousands of genomes. Nat Methods. 2012;9:179–81.CrossRef Delaneau O, Marchini J, Zagury J-F. A linear complexity phasing method for thousands of genomes. Nat Methods. 2012;9:179–81.CrossRef
17.
go back to reference Fuchsberger C, Abecasis GR, Hinds DA. minimac2: faster genotype imputation. Bioinformatics. 2015;31:782–4.PubMedCrossRef Fuchsberger C, Abecasis GR, Hinds DA. minimac2: faster genotype imputation. Bioinformatics. 2015;31:782–4.PubMedCrossRef
18.
go back to reference Sollis E, Mosaku A, Abid A, Buniello A, Cerezo M, Gil L, et al. The NHGRI-EBI GWAS Catalog: knowledgebase and deposition resource. Nucleic Acids Res. 2023;51:D977–85.PubMedCrossRef Sollis E, Mosaku A, Abid A, Buniello A, Cerezo M, Gil L, et al. The NHGRI-EBI GWAS Catalog: knowledgebase and deposition resource. Nucleic Acids Res. 2023;51:D977–85.PubMedCrossRef
19.
go back to reference Beck T, Shorter T, Brookes AJ. GWAS Central: a comprehensive resource for the discovery and comparison of genotype and phenotype data from genome-wide association studies. Nucleic Acids Res. 2020;48:D933–40.PubMed Beck T, Shorter T, Brookes AJ. GWAS Central: a comprehensive resource for the discovery and comparison of genotype and phenotype data from genome-wide association studies. Nucleic Acids Res. 2020;48:D933–40.PubMed
21.
go back to reference Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37:658–65.PubMedPubMedCentralCrossRef Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37:658–65.PubMedPubMedCentralCrossRef
22.
go back to reference Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44:512–25.PubMedPubMedCentralCrossRef Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44:512–25.PubMedPubMedCentralCrossRef
23.
go back to reference Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40:304–14.PubMedPubMedCentralCrossRef Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40:304–14.PubMedPubMedCentralCrossRef
24.
25.
go back to reference Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7: e34408.PubMedPubMedCentralCrossRef Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7: e34408.PubMedPubMedCentralCrossRef
26.
go back to reference Zhou W, Nielsen JB, Fritsche LG, Dey R, Gabrielsen ME, Wolford BN, et al. Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies. Nat Genet. 2018;50:1335–41.PubMedPubMedCentralCrossRef Zhou W, Nielsen JB, Fritsche LG, Dey R, Gabrielsen ME, Wolford BN, et al. Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies. Nat Genet. 2018;50:1335–41.PubMedPubMedCentralCrossRef
28.
go back to reference Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38: e164-e.CrossRef Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38: e164-e.CrossRef
30.
go back to reference Jang J, Cho E-J, Hwang Y, Weiderpass E, Ahn C, Choi J, et al. Association between body mass index and gastric cancer risk according to effect modification by helicobacter pylori infection. Cancer Res Treatment. 2019;51:1107.CrossRef Jang J, Cho E-J, Hwang Y, Weiderpass E, Ahn C, Choi J, et al. Association between body mass index and gastric cancer risk according to effect modification by helicobacter pylori infection. Cancer Res Treatment. 2019;51:1107.CrossRef
31.
go back to reference Jang J, Wang T, Cai H, Ye F, Murphy G, Shimazu T, et al. The U-shaped association between body mass index and gastric cancer risk in the Helicobacter pylori Biomarker Cohort Consortium: a nested case–control study from eight East Asian cohort studies. Int J Cancer. 2020;147:777–84.PubMedCrossRef Jang J, Wang T, Cai H, Ye F, Murphy G, Shimazu T, et al. The U-shaped association between body mass index and gastric cancer risk in the Helicobacter pylori Biomarker Cohort Consortium: a nested case–control study from eight East Asian cohort studies. Int J Cancer. 2020;147:777–84.PubMedCrossRef
32.
go back to reference Fund WCR. Body fatness and weight gain and the risk of cancer. WCRF. 2018. Fund WCR. Body fatness and weight gain and the risk of cancer. WCRF. 2018.
33.
go back to reference Yang P, Zhou Y, Chen B, Wan HW, Jia GQ, Bai HL, et al. Overweight, obesity and gastric cancer risk: results from a meta-analysis of cohort studies. Eur J Cancer. 2009;45:2867–73.PubMedCrossRef Yang P, Zhou Y, Chen B, Wan HW, Jia GQ, Bai HL, et al. Overweight, obesity and gastric cancer risk: results from a meta-analysis of cohort studies. Eur J Cancer. 2009;45:2867–73.PubMedCrossRef
34.
go back to reference Chen Y, Liu L, Wang X, Wang J, Yan Z, Cheng J, et al. Body mass index and risk of gastric cancer: a meta-analysis of a population with more than ten million from 24 prospective studies. Cancer Epidemiol Biomarkers Prev. 2013;22:1395–408.PubMedCrossRef Chen Y, Liu L, Wang X, Wang J, Yan Z, Cheng J, et al. Body mass index and risk of gastric cancer: a meta-analysis of a population with more than ten million from 24 prospective studies. Cancer Epidemiol Biomarkers Prev. 2013;22:1395–408.PubMedCrossRef
35.
go back to reference Lin X-J, Wang C-P, Liu X-D, Yan K-K, Li S, Bao H-H, et al. Body mass index and risk of gastric cancer: a meta-analysis. Jpn J Clin Oncol. 2014;44:783–91.PubMedCrossRef Lin X-J, Wang C-P, Liu X-D, Yan K-K, Li S, Bao H-H, et al. Body mass index and risk of gastric cancer: a meta-analysis. Jpn J Clin Oncol. 2014;44:783–91.PubMedCrossRef
36.
go back to reference Bhaskaran K, Douglas I, Forbes H, dos Santos-Silva I, Leon DA, Smeeth L. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults. Lancet. 2014;384:755–65.PubMedPubMedCentralCrossRef Bhaskaran K, Douglas I, Forbes H, dos Santos-Silva I, Leon DA, Smeeth L. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults. Lancet. 2014;384:755–65.PubMedPubMedCentralCrossRef
37.
go back to reference Fan J, Wang J, Wang S, Abnet CC, Qiao Y, Taylor PR. Body mass index and risk of gastric cancer: a 30-year follow-up study in the Linxian general population trial cohort. Cancer Sci. 2017;108:1667–72.PubMedPubMedCentralCrossRef Fan J, Wang J, Wang S, Abnet CC, Qiao Y, Taylor PR. Body mass index and risk of gastric cancer: a 30-year follow-up study in the Linxian general population trial cohort. Cancer Sci. 2017;108:1667–72.PubMedPubMedCentralCrossRef
38.
go back to reference World Health Organization Regional Office for the Western Pacific. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia; 2000. World Health Organization Regional Office for the Western Pacific. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia; 2000.
39.
go back to reference Honda M, Wong SL, Healy MA, Nakajima T, Watanabe M, Fukuma S, et al. Long-term trends in primary sites of gastric adenocarcinoma in Japan and the United States. J Cancer. 2017;8:1935.PubMedPubMedCentralCrossRef Honda M, Wong SL, Healy MA, Nakajima T, Watanabe M, Fukuma S, et al. Long-term trends in primary sites of gastric adenocarcinoma in Japan and the United States. J Cancer. 2017;8:1935.PubMedPubMedCentralCrossRef
40.
go back to reference Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer. 2008;8:915–28.PubMedCrossRef Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer. 2008;8:915–28.PubMedCrossRef
41.
go back to reference Greer KB, Thompson CL, Brenner L, Bednarchik B, Dawson D, Willis J, et al. Association of insulin and insulin-like growth factors with Barrett’s oesophagus. Gut. 2012;61:665–72.PubMedCrossRef Greer KB, Thompson CL, Brenner L, Bednarchik B, Dawson D, Willis J, et al. Association of insulin and insulin-like growth factors with Barrett’s oesophagus. Gut. 2012;61:665–72.PubMedCrossRef
42.
go back to reference Franciosi CM, Piacentini MG, Conti M, Romano F, Musco F, Caprotti R, et al. IGF-1 and IGF-1BP3 in gastric adenocarcinoma. Preliminary Study Hepato-Gastroenterol. 2003;50:297–300. Franciosi CM, Piacentini MG, Conti M, Romano F, Musco F, Caprotti R, et al. IGF-1 and IGF-1BP3 in gastric adenocarcinoma. Preliminary Study Hepato-Gastroenterol. 2003;50:297–300.
43.
go back to reference Ishikawa M, Kitayama J, Kazama S, Hiramatsu T, Hatano K, Nagawa H. Plasma adiponectin and gastric cancer. Clin Cancer Res. 2005;11:466–72.PubMedCrossRef Ishikawa M, Kitayama J, Kazama S, Hiramatsu T, Hatano K, Nagawa H. Plasma adiponectin and gastric cancer. Clin Cancer Res. 2005;11:466–72.PubMedCrossRef
45.
go back to reference Joo Y-E, Park H-K, Myung D-S, Baik G-H, Shin J-E, Seo G-S, et al. Prevalence and risk factors of atrophic gastritis and intestinal metaplasia: a nationwide multicenter prospective study in Korea. Gut and liver. 2013;7:303.PubMedPubMedCentralCrossRef Joo Y-E, Park H-K, Myung D-S, Baik G-H, Shin J-E, Seo G-S, et al. Prevalence and risk factors of atrophic gastritis and intestinal metaplasia: a nationwide multicenter prospective study in Korea. Gut and liver. 2013;7:303.PubMedPubMedCentralCrossRef
47.
go back to reference Bird JK, Murphy RA, Ciappio ED, McBurney MI. Risk of deficiency in multiple concurrent micronutrients in children and adults in the United States. Nutrients. 2017;9:655.PubMedPubMedCentralCrossRef Bird JK, Murphy RA, Ciappio ED, McBurney MI. Risk of deficiency in multiple concurrent micronutrients in children and adults in the United States. Nutrients. 2017;9:655.PubMedPubMedCentralCrossRef
51.
go back to reference Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked? Free Radical Biol Med. 2010;49:1603–16.CrossRef Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked? Free Radical Biol Med. 2010;49:1603–16.CrossRef
53.
go back to reference Joo YE, Park HK, Myung DS, Baik GH, Shin JE, Seo GS, et al. Prevalence and risk factors of atrophic gastritis and intestinal metaplasia: a nationwide multicenter prospective study in Korea. Gut Liver. 2013;7:303–10.PubMedPubMedCentralCrossRef Joo YE, Park HK, Myung DS, Baik GH, Shin JE, Seo GS, et al. Prevalence and risk factors of atrophic gastritis and intestinal metaplasia: a nationwide multicenter prospective study in Korea. Gut Liver. 2013;7:303–10.PubMedPubMedCentralCrossRef
54.
go back to reference Kim HJ, Yoo TW, Park DI, Park JH, Cho YK, Sohn CI, et al. Influence of overweight and obesity on upper endoscopic findings. J Gastroenterol Hepatol. 2007;22:477–81.PubMedCrossRef Kim HJ, Yoo TW, Park DI, Park JH, Cho YK, Sohn CI, et al. Influence of overweight and obesity on upper endoscopic findings. J Gastroenterol Hepatol. 2007;22:477–81.PubMedCrossRef
55.
go back to reference Watabe H, Mitsushima T, Derakhshan MH, Yamaji Y, Okamoto M, Kawabe T, et al. Study of association between atrophic gastritis and body mass index: a cross-sectional study in 10,197 Japanese subjects. Dig Dis Sci. 2009;54:988–95.PubMedCrossRef Watabe H, Mitsushima T, Derakhshan MH, Yamaji Y, Okamoto M, Kawabe T, et al. Study of association between atrophic gastritis and body mass index: a cross-sectional study in 10,197 Japanese subjects. Dig Dis Sci. 2009;54:988–95.PubMedCrossRef
56.
go back to reference Smith GD, Ebrahim S. ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32:1–22.PubMedCrossRef Smith GD, Ebrahim S. ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32:1–22.PubMedCrossRef
57.
go back to reference Burgess S, Bowden J, Fall T, Ingelsson E, Thompson SG. Sensitivity analyses for robust causal inference from Mendelian randomization analyses with multiple genetic variants. Epidemiology. 2017;28:30–42.PubMedCrossRef Burgess S, Bowden J, Fall T, Ingelsson E, Thompson SG. Sensitivity analyses for robust causal inference from Mendelian randomization analyses with multiple genetic variants. Epidemiology. 2017;28:30–42.PubMedCrossRef
58.
go back to reference Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017;46:1985–98.PubMedPubMedCentralCrossRef Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017;46:1985–98.PubMedPubMedCentralCrossRef
59.
go back to reference Burgess S, Thompson SG, Collaboration CCG. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40:755–64.PubMedCrossRef Burgess S, Thompson SG, Collaboration CCG. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40:755–64.PubMedCrossRef
60.
go back to reference Evans DM, Davey SG. Mendelian randomization: new applications in the coming age of hypothesis-free causality. Annu Rev Genomics Hum Genet. 2015;16:327–50.PubMedCrossRef Evans DM, Davey SG. Mendelian randomization: new applications in the coming age of hypothesis-free causality. Annu Rev Genomics Hum Genet. 2015;16:327–50.PubMedCrossRef
Metadata
Title
Ethnic-specific associations between body mass index and gastric cancer: a Mendelian randomization study in European and Korean populations
Authors
Sangjun Lee
Sue K. Park
Publication date
02-11-2023
Publisher
Springer Nature Singapore
Published in
Gastric Cancer / Issue 1/2024
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-023-01439-5

Other articles of this Issue 1/2024

Gastric Cancer 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.